| [1] | Alwan, A., Armstrong, T., Bettcher, D., Boerma, T., Branca, F., Ho, J. C.Y., Mathers, C., Martinez, R., Poznyak, V., Roglic, G., Riley, L., d`Espaignet, E., Stevens, G., Taubert, K. and Xuereb, G. Global atlas on cardiovascular disease prevention and control, by the World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, 2011. |
| |
| [2] | Riley, L. and Cowan, M. Noncommunicable diseases (NCD). Country Profiles. Switzerland: World Health Organization, 2014. https://www.who.int/nmh/publications/ncd-profiles-2014/en/. |
| |
| [3] | Wallace, T.C. Anthocyanin in cardiovascular disease. Advances in Nutrition, 2(1):1-7.2011. |
| |
| [4] | Khoo, H.E., Azlan, A., Ismail, A., Abas, F. and Hamid, M. Inhibition of Oxidative Stress and Lipid Peroxidation by Anthocyanins from Defatted. Canarium odontophyllum. Pericarp and Peel Using In Vitro Bioassays. PLoS ONE, 9; 9(1): e81447. 2014. |
| |
| [5] | Hopkins, A.L., Lamm, M.G., Funk, J.L. and Ritenbaugh, C.h. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidaemia: a comprehensive review of animal and human studies. Fitoterapia. 85: 84-94.2013. |
| |
| [6] | Mozaffari-Khosravi, H., Jalali-Khanabadi, B.A., Afkhami-Ardekani, M. and Fatehi, F. Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med, 15(8): 899-903. 2009. |
| |
| [7] | Jin, Y., Alimbetov, D., George, T., Gordon, M.H. and Lovegrove, J.A. A randomised trial to investigate the effects of acute consumption of a blackcurrant juice drink on markers of vascular reactivity and bioavailability of anthocyanins in human subjects. Eur J Clin Nutr, 65(7): 849-56.2011. |
| |
| [8] | McKay, D.L., Chen, C.Y., Saltzman, E. and Blumberg, J.B. Hibiscus Sabdariffa L. Tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr, 140(2): 298-303.2010. |
| |
| [9] | Mazza, G.J. Anthocyanins and heart health. Ann Ist Super Sanita, 43(4): 369-74. 2007. |
| |
| [10] | Hollander, W. Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol, 38(6): 786-800. 1976. |
| |
| [11] | Hadi, H.A.R., Carr, C.S. and Al Suwaidi, J. Endothelial dysfunction: cardiovascular risk factors, therapy and outcome. Vasc Health Risk Manag, 1(3): 183-98. 2005. |
| |
| [12] | Yi, L., Chen, Ch-y., Jin, X., Mi, M-t., Yu, B., Chang, H., Ling, W-h. and Zhang, T. Structural requirements of anthocyanins in relation to inhibition of endothelial injury induced by oxidized low-density lipoprotein and correlation with radical scavenging activity. FEBS Lett, 3(5): 583-590. 2010. |
| |
| [13] | Chang, Y.C., Huang, K.X., Huang, A.C., Ho, Y.C. and Wang, C.J. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and OxLDL-mediated macrophages apoptosis. Food Chem Toxicol, 44(7): 1015-23. 2006. |
| |
| [14] | Aziz, Z., Wong, S.Y. and Chong, N.J. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol, 150(2): 442-50. 2013. |
| |
| [15] | Lefevre, M., Wiles, J.E., Zhang, X., Howard, L.R., Gupta, S., Smith, A.A., Ju, Z.Y. and DeLany, J.P. Gene expression microarray analysis of the effects of grape anthocyanins in mice: a test of a hypothesis-generating paradigm. Metabolism, 57(suppl 1): S52-S57. 2008. |
| |
| [16] | Da-Costa-Rocha, I., BonnLaender, B., Sievers, H., Pischel, I. and Heinrich, M. Hibiscus sabdariffa L. A phytochemical and pharmacological review. Food Chem, 15; 165: 424-443. 2014. |
| |
| [17] | Mauray, A., Felgines, C., Morand, C., Mazur, A., Scalbert, A. and Milenkovic, D. Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice. Genes Nutr, 5(4): 343-353. 2010. |
| |
| [18] | Mauray, A., Felgines, C., Morand, C., Mazur, A., Scalbert, A. and Milenkovic, D. Bilberry anthocyanin-rich extract alters expression of genes related to atherosclerosis development in aorta of apo E-deficient mice. Nutr Metab Cardiovasc Dis, 22(1): 72-80. 2012. |
| |